Scientific Perspectives & Industry Briefs

Reading scientific evidence and health-technology change through the same framework.

Peer-reviewed science on one side; emerging technologies, regulation and market movement on the other. Both are examined through a critical Türkiye perspective.

Editorial visual representing scientific publication, neuroscience and health-technology assessment

Scientific Perspectives

Reading the literature through mechanism, evidence quality and clinical meaning.

Referenced writing on neurodegeneration, extracellular vesicles, biomarkers, mitochondria, neuroinflammation and emerging therapeutic approaches.

Industry Briefs

Assessing global health-technology developments from a Türkiye perspective.

New devices, clinical AI, robotics, regulatory decisions and market access viewed through the question: what could this mean in Türkiye?

Neurotechnology and brain-computer interfacesRobotic rehabilitation and physical AIClinical AI, digital health and data platformsRegulation, reimbursement and Türkiye market access

Scientific Perspectives

Verified peer-reviewed publications

Submitted or under-review manuscripts are not included in this list.

2024Original research

Cannabidiol and cannabigerol effect on cognitive deficit induced by intracerebroventricular administration of amyloid beta 42 in experimental Alzheimer’s disease model

Indian Journal of Experimental Biology · 62(12), 937–948

Open source ↗

2020Single-author review

Alzheimer’s Disease and Dementia

Journal of Literature Pharmacy Sciences · 9(2), 125–136

Peer-reviewed review

Editorial Focus

Keeping scientific expertise aligned with emerging health technologies.

Neuroscience and neurodegenerative disease

Neurotechnology and neuromodulation

Rehabilitation and functional-recovery technologies

Digital health, clinical AI and remote monitoring

Emerging biotechnologies and regenerative approaches

Evidence, applicability and the Türkiye market perspective in health technology